in 1999 , members of the recombinant dna advisory committee pointed out , a young man died in a now - infamous gene therapy trial at penn in which the lead scientist had a multimillion - dollar financial stake in the technology . that conflict of interest , scholars have argued , may have led him to make dangerous decisions . although the parker institute will handle patents for any discoveries that emerge from the research it funds , " each site owns its intellectual property , " said chief legal counsel melinda griffith . " if you invent it , you own it . "